Dark Blue Therapeutics, a UK discovery and development biotech developing precision oncology medicines, has announced the appointment of Edwin Moses as chairman.

Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical ...

AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and ...

Oncologists share how to prioritize yourself while undergoing the difficult treatment, and real women share how positive ...

Xilio Therapeutics (NASDAQ:XLO – Get Free Report) is projected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.22 ...

Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for shares of Maze Therapeutics in ...

Edgewise Therapeutics (EWTX) fell 10.6% in premarket trade after it priced its offering to raise $200 million.

Perspective Therapeutics (CATX) has been on a downward spiral lately with significant selling pressure. After declining 16.6% ...

Corcept Therapeutics (CORT) closed the last trading session at $91.93, gaining 64.2% over the past four weeks, but there ...

LENZ Therapeutics (LENZ) has filed to sell 13M shares of common stock for holders. This prospectus is not an offer to sell. Filing ...

As the days get longer and the weather warms up, it’s the perfect time to get your bike ready for the season,” according to a news release. “Join the Northcentral Pennsylvania Conservancy and ...